Rock SpringsCapital
News,Biotech / MedTech,Singapore,Investments
MiRXES secures $77M Series C funding to accelerate multi-cancer early detection pipeline
Led by CR-CP Life Science Fund, this new capital will support MiRXES’s growth as a global leader in cancer early detection tests and preventive healthcare.
July 8, 2021
Bukalapak’s revenue up 1 percent in third quarter
October 29, 2025
Creador appoints Syed Yasir Arafat as Senior Advisor
October 29, 2025
Bukalapak’s revenue up 1 percent in third quarter
October 29, 2025
Creador appoints Syed Yasir Arafat as Senior Advisor
October 29, 2025




